Sun I-Feng, Lee Su-Shin, Lin Sin-Daw, Lai Chung-Sheng
Division of Plastic and Reconstructive Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Kaohsiung J Med Sci. 2007 Jul;23(7):344-51. doi: 10.1016/S1607-551X(09)70420-6.
Acute renal failure (ARF) is a very common condition that may occur in patients with major burn injuries. The majority of burn patients with ARF have a high mortality rate, ranging from 73% to 100%. There are several ways to treat ARF in burn patients, including peritoneal dialysis (PD), intermittent hemodialysis, and continuous renal replacement therapy (CRRT). CRRT is generally used in patients in whom intermittent hemodialysis has failed to control hypovolemia, as well as in patients who cannot tolerate intermittent hemodialysis. Additionally, PD is not suitable for patients with burns within the abdominal area. For these reasons, most patients with unstable hemodynamic conditions receive CRRT. In this study (conducted in our burn unit between 1997 and 2004), six burn patients received CRRT: three received continuous arteriovenous hemodialysis (CAVHD) and the other three received continuous venovenous hemofiltration (CVVH). The patients were all males, with a mean age of 49.8 years (range, 27-80 years), and a mean burnt surface area of 65.1% (range, 30-95%). Four patients died due to multiple organ failure, and two patients recovered from severe ARF. CRRT has been proven safe and useful for burn patients with ARF. According to this study, we conclude that CVVH is an appropriate tool for treating ARF, with a lower incidence of vascular complications than CAVHD.
急性肾衰竭(ARF)是一种常见病症,可发生于重度烧伤患者。大多数患有ARF的烧伤患者死亡率很高,在73%至100%之间。治疗烧伤患者ARF有多种方法,包括腹膜透析(PD)、间歇性血液透析和连续性肾脏替代疗法(CRRT)。CRRT通常用于间歇性血液透析无法控制血容量不足的患者,以及无法耐受间歇性血液透析的患者。此外,PD不适用于腹部有烧伤的患者。由于这些原因,大多数血流动力学状况不稳定的患者接受CRRT治疗。在本研究(于1997年至2004年在我们的烧伤科进行)中,6名烧伤患者接受了CRRT治疗:3名接受连续性动静脉血液透析(CAVHD),另外3名接受连续性静脉-静脉血液滤过(CVVH)。患者均为男性,平均年龄49.8岁(范围27 - 80岁),平均烧伤面积65.1%(范围30 - 95%)。4名患者因多器官功能衰竭死亡,2名患者从严重ARF中康复。CRRT已被证明对患有ARF的烧伤患者安全且有用。根据本研究,我们得出结论,CVVH是治疗ARF的合适工具,其血管并发症发生率低于CAVHD。